Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $337,512 - $410,084
1,337 New
1,337 $370,000
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $479,164 - $569,816
2,555 New
2,555 $521,000
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $719,661 - $906,735
-3,714 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $7.1 Million - $9.13 Million
-31,728 Reduced 89.52%
3,714 $891,000
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $7 Million - $9.13 Million
24,737 Added 231.08%
35,442 $10 Million
Q2 2021

Aug 06, 2021

BUY
$259.0 - $414.71 $865,578 - $1.39 Million
3,342 Added 45.39%
10,705 $3.71 Million
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $1.79 Million - $2.1 Million
7,363 New
7,363 $2.06 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $270,594 - $312,435
-1,022 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $98,808 - $130,854
382 Added 59.69%
1,022 $273,000
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $206,745 - $262,259
-769 Reduced 54.58%
640 $202,000
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $623,209 - $861,126
-2,832 Reduced 66.78%
1,409 $418,000
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $71,537 - $80,236
329 Added 8.41%
4,241 $987,000
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $676,948 - $746,189
3,087 Added 374.18%
3,912 $915,000
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $48,671 - $58,005
189 Added 29.72%
825 $239,000
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $195,659 - $219,152
636
636 $203,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.